Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.86B | 6.04B | 6.11B | 8.02B | 8.45B | 6.02B |
Gross Profit | 805.00M | 866.00M | 906.00M | 1.55B | 1.77B | 1.10B |
EBITDA | 207.00M | 329.00M | 442.00M | 1.09B | 1.65B | 560.00M |
Net Income | -322.00M | -189.00M | 101.00M | 460.00M | 1.04B | 291.00M |
Balance Sheet | ||||||
Total Assets | 7.15B | 7.11B | 7.25B | 8.22B | 9.39B | 8.71B |
Cash, Cash Equivalents and Short-Term Investments | 399.00M | 340.00M | 540.00M | 654.00M | 1.04B | 1.59B |
Total Debt | 2.44B | 2.24B | 2.07B | 1.74B | 1.55B | 2.12B |
Total Liabilities | 4.09B | 3.95B | 3.77B | 4.38B | 4.83B | 5.04B |
Stockholders Equity | 2.83B | 2.96B | 3.25B | 3.62B | 4.38B | 3.52B |
Cash Flow | ||||||
Free Cash Flow | 135.00M | 79.00M | -21.00M | 642.00M | 610.00M | 4.00M |
Operating Cash Flow | 300.00M | 263.00M | 209.00M | 914.00M | 952.00M | 253.00M |
Investing Cash Flow | -78.00M | -126.00M | 305.00M | -260.00M | -524.00M | 1.46B |
Financing Cash Flow | -155.00M | -326.00M | -620.00M | -994.00M | -977.00M | -655.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $521.58M | 6.84 | 9.85% | 3.19% | 1.31% | 796.76% | |
55 Neutral | $16.56B | 75.91 | -5.59% | 12.05% | -2.82% | -186.41% | |
50 Neutral | $1.74B | ― | -10.43% | 9.95% | -1.56% | -259.58% | |
47 Neutral | $4.65B | 6.84 | -25.69% | 1.83% | -5.83% | -183.85% | |
45 Neutral | $567.52M | ― | -14.11% | 10.42% | 0.20% | -292.54% | |
44 Neutral | C$930.37M | -8.96 | -0.02% | 2.69% | 23.24% | -42.45% | |
42 Neutral | $1.20B | ― | -8638.28% | ― | -3.33% | 44.37% |
On May 23, 2025, Huntsman International LLC amended its 2022 Revolving Credit Agreement to adjust financial covenants, specifically increasing the maximum permitted leverage ratio through December 31, 2026. This amendment aims to provide financial flexibility by reducing general debt and liens baskets and limiting restricted payments during the Covenant Relief Period, impacting the company’s financial operations and stakeholder interests.
The most recent analyst rating on (HUN) stock is a Buy with a $27.00 price target. To see the full list of analyst forecasts on Huntsman stock, see the HUN Stock Forecast page.